NEW YORK (GenomeWeb) – DiaSorin and the Tecan Group today announced a collaboration to develop a nucleic acid extraction platform.

Financial and other terms of the deal were not disclosed.

The new platform will leverage Tecan's Fluent Laboratory Automation Solution along with DiaSoriin's Liaison MDX PCR system to provide users a complete sample-to-result system, the firms said, adding the Fluent instrument will be optimized for use with DiaSorin's extraction chemistry and automated PCR technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.